Trade RVMD anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Revolution Medicines, Inc. (RVMD) is trading at US$206.28, down 6.72% today as of Aug 28, 13:01 EDT. The company has a market capitalisation of US$44.89B. Over the past 52 weeks, RVMD has traded between US$37.56 and US$224.31. On Syfe you can trade RVMD with $0 commission and add it to your watchlist.
| Previous close | US$221.15 |
|---|---|
| Market cap | US$44.89B |
| 52-week range | US$37.56 – US$224.31 |
| Volume | 3.36M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Revolution Medicines, Inc.
Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.
Year: 2020
Revolution Medicines, Inc. (RVMD) stock is trading at US$206.28, -6.72% from the previous close of US$221.15.
The market cap for Revolution Medicines, Inc. (RVMD) stock is approximately US$44.89B.
The 52-week high for Revolution Medicines, Inc. (RVMD) stock is US$224.31.
The 52-week low for Revolution Medicines, Inc. (RVMD) stock is US$37.56.
Revolution Medicines, Inc. (RVMD) does not currently pay a dividend.
Stay on top of RVMD
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
